Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cancers|September 28, 2021
Serum Levels of the Cytokine TWEAK Are Associated with Metabolic Status in Patients with Prostate Cancer and Modulate Cancer Cell Lipid Metabolism In VitroAntonio Altuna-Coy, Xavier Ruiz-Plazas, Marta Alves-Santiago, et al.The Journal of Urology|August 12, 2005
Multivariate analysis of clinical parameters of synchronous primary superficial bladder cancer and upper urinary tract tumorJuan Palou, Federico Rodríguez-Rubio, Jorge Huguet, et al.Archivos Espanoles De Urologia|November 29, 2002
[Efficacy of finasteride in the treatment of hematuria associated with benign prostatic hypertrophy]Juan Palou Redorta, Luis Gausa Gascon, José Salvador Bayarre, et al.Transplantation|December 6, 2003
Intravesical bacillus Calmette-Guèrin for the treatment of superficial bladder cancer in renal transplant patientsJuan Palou, Oriol Angerri, José Segarra, et al.Cancers|January 14, 2021
Liquid Biopsy-Based Exo-oncomiRNAs Can Predict Prostate Cancer AggressivenessXavier Ruiz-Plazas, Antonio Altuna-Coy, Marta Alves-Santiago, et al.BMC Medicine|August 17, 2022
The lipidomic profile of the tumoral periprostatic adipose tissue reveals alterations in tumor cell's metabolic crosstalkAntonio Altuna-Coy, Xavier Ruiz-Plazas, Silvia Sánchez-Martin, et al.Journal of Translational Medicine|July 15, 2024
Tumoral periprostatic adipose tissue exovesicles-derived miR-20a-5p regulates prostate cancer cell proliferation and inflammation through the RORA geneSilvia Sánchez-Martin, Antonio Altuna-Coy, Verónica Arreaza-Gil, et al.Journal of Translational Medicine|September 11, 2019
Biofluid quantification of TWEAK/Fn14 axis in combination with a selected biomarker panel improves assessment of prostate cancer aggressivenessXavier Ruiz-Plazas, Esther Rodríguez-Gallego, Marta Alves, et al.The Journal of Urology|August 27, 2025
A semen panel signature comprising sTWEAK Cytokine levels and expression of exomiR-221-3p and exomiR-222-3p for assessing prostate cancer prognosis, diagnostic utility, and detection of upgrading during active surveillanceMarta Alves-Santiago, Antonio Altuna-Coy, Pablo López-Ribelles, et al.Pageof 2